Abstract
Homeostasis of most tissues and organs is maintained by tissue-specific somatic or adult stem cells (SCs) and their early progenitors possessing two main properties: self-renewal and differentiation. To fulfil these two functions, they must undergo either symmetrical division for stem cell expansion, necessary after injury for example, or asymmetrical division for stem cell maintenance and progenitor production. The “cancer stem cell hypothesis” postulates that tumours arise from adult stem cells called cancer stem cells (CSCs) that possess stem cell properties. There is growing evidence that most solid tumours and haematological malignancies are driven by CSCs as a result of advances in stem cell biology and the development of animal models. This has fundamental implications for understanding the biology of cancers and also for developing new therapeutic strategies. The recent characterisation of CSC in head and neck squamous cell carcinoma (HNSCC) prompted us to re-examine the disease development and to discuss the limited effects of conventional therapies.
Keywords: Stem cell, cancer stem cell, p63, head and neck squamous cell carcinoma, oral epithelium
Current Cancer Therapy Reviews
Title: Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Volume: 5 Issue: 2
Author(s): Mathilde Lechevrel and Brigitte Sola
Affiliation:
Keywords: Stem cell, cancer stem cell, p63, head and neck squamous cell carcinoma, oral epithelium
Abstract: Homeostasis of most tissues and organs is maintained by tissue-specific somatic or adult stem cells (SCs) and their early progenitors possessing two main properties: self-renewal and differentiation. To fulfil these two functions, they must undergo either symmetrical division for stem cell expansion, necessary after injury for example, or asymmetrical division for stem cell maintenance and progenitor production. The “cancer stem cell hypothesis” postulates that tumours arise from adult stem cells called cancer stem cells (CSCs) that possess stem cell properties. There is growing evidence that most solid tumours and haematological malignancies are driven by CSCs as a result of advances in stem cell biology and the development of animal models. This has fundamental implications for understanding the biology of cancers and also for developing new therapeutic strategies. The recent characterisation of CSC in head and neck squamous cell carcinoma (HNSCC) prompted us to re-examine the disease development and to discuss the limited effects of conventional therapies.
Export Options
About this article
Cite this article as:
Lechevrel Mathilde and Sola Brigitte, Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma, Current Cancer Therapy Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339409788166797
DOI https://dx.doi.org/10.2174/157339409788166797 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Trends in Anti-Cancer Therapy: Combining Conventional Chemotherapeutics with Novel Immunomodulators
Current Medicinal Chemistry Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis
Current Medicinal Chemistry Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells
Current Pharmaceutical Design Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Current Pharmaceutical Design Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Current Pharmaceutical Design Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy.
Current Molecular Medicine Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Current Drug Targets From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma
Current Cancer Drug Targets The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
Current Medicinal Chemistry Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets Targeting the Epidermal Growth Factor Receptor: Exploring the Potential of Novel Inhibitor N-(3-Ethynylphenyl)-6, 7-bis (2-methoxyethoxy) Quinolin- 4-Amine Using Docking and Molecular Dynamics Simulation
Protein & Peptide Letters Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects
Current Medicinal Chemistry Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities
Current Drug Metabolism Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action
Current Medicinal Chemistry Infection, Stem Cells and Cancer Signals
Current Pharmaceutical Biotechnology Prostaglandins Pathway as a Possible Biological Link Between Cancer and Major Depression
Current Angiogenesis (Discontinued) Aminopeptidases in Cancer, Biology and Prospects for Pharmacological Intervention
Current Cancer Drug Targets Animal Venoms have Potential to Treat Cancer
Current Topics in Medicinal Chemistry Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Clinical Cancer Drugs